• We are pleased to announce that the winner of our Feedback Prize Draw for the Winter 2024-25 session and winning £150 of gift vouchers is Zhao Liang Tay. Congratulations to Zhao Liang. If you fancy winning £150 worth of gift vouchers (from a major UK store) for the Summer 2025 exam sitting for just a few minutes of your time throughout the session, please see our website at https://www.acted.co.uk/further-info.html?pat=feedback#feedback-prize for more information on how you can make sure your name is included in the draw at the end of the session.
  • Please be advised that the SP1, SP5 and SP7 X1 deadline is the 14th July and not the 17th June as first stated. Please accept out apologies for any confusion caused.

Mortality surplus in an annuity fund

A

ActuaryEye

Member
Most PPFMs that I have come across specify that mortality surpluses from annuitant mortality experience in an annuity fund belongs to policyholders. These funds are 90:10. Is there a specific reason why shareholders don’t participate in the mortality profit? I thought shareholder would also be entitled to a share in the surpluses since they also bear the risk if annuitants live longer than expected (mortality lighter than expected).
 
Yes, you are right, in a traditional 90:10 fund, surplus is split - 90% to policyholders and 10% to shareholders. And this comes through via the bonus system. Can I just check whether it is still a 90:10 structure when the policy becomes an annuity? You may also want to consider whether there has historically been approved reallocation of surplus between shareholder and policyholders.
 
Back
Top